Activation of Nrf2 Signaling Augments Vesicular Stomatitis Virus Oncolysis via Autophagy-Driven Suppression of Antiviral Immunity.

Activation of Nrf2 Signaling Augments Vesicular Stomatitis Virus Oncolysis via Autophagy-Driven Suppression of Antiviral Immunity.
复制标题

DOI:
10.1016/j.ymthe.2017.04.022
复制
发表时间:
2017-08-02
期刊:
Molecular therapy : the journal of the American Society of Gene Therapy
影响因子:
--
通讯作者:
Lin R
Lin R
中科院分区:
其他
文献类型:
--
作者:
Olagnier D;Lababidi RR;Hadj SB;Sze A;Liu Y;Naidu SD;Ferrari M;Jiang Y;Chiang C;Beljanski V;Goulet ML;Knatko EV;Dinkova-Kostova AT;Hiscott J;Lin R

文献摘要

参考文献

被引文献

相似文献

溶瘤病毒(OVs)为治疗多种类型的癌症提供了一种很有前途的治疗方法。在这项研究中,我们发现通过转录因子Nrf2对抗氧化网络的操纵增加了水泡性口炎病毒Δ51 (VSVΔ51)的复制,并使癌细胞对病毒溶瘤变敏感。抗氧化化合物萝卜硫素(SFN)激活Nrf2信号可增强VSVΔ51在ov耐药癌细胞中的扩散,并改善不同小鼠同种和异种移植肿瘤模型的治疗效果。耐化疗的A549肺癌细胞表现出Nrf2信号的构成性显性超激活,特别容易发生VSVΔ51溶瘤。从机制上讲,Nrf2信号的增强刺激了癌细胞中的病毒复制,并通过增加自噬破坏了I型IFN反应。这项研究揭示了Nrf2在调节自噬和先天抗病毒反应中的作用,这种作用补充了vsv导向的肿瘤溶解治疗多种类型的ov耐药或化疗耐药癌症的潜力。溶瘤病毒为治疗癌症提供了一种很有前途的治疗方法。在这一期中,Olagnier等人证明了抗氧化剂化合物萝卜硫素激活转录调节因子Nrf2,从而抑制先天抗病毒反应,刺激自噬,增强水泡性口炎病毒对肿瘤细胞的溶瘤作用。
Oncolytic viruses (OVs) offer a promising therapeutic approach to treat multiple types of cancer. In this study, we show that the manipulation of the antioxidant network via transcription factor Nrf2 augments vesicular stomatitis virus Δ51 (VSVΔ51) replication and sensitizes cancer cells to viral oncolysis. Activation of Nrf2 signaling by the antioxidant compound sulforaphane (SFN) leads to enhanced VSVΔ51 spread in OV-resistant cancer cells and improves the therapeutic outcome in different murine syngeneic and xenograft tumor models. Chemoresistant A549 lung cancer cells that display constitutive dominant hyperactivation of Nrf2 signaling are particularly vulnerable to VSVΔ51 oncolysis. Mechanistically, enhanced Nrf2 signaling stimulated viral replication in cancer cells and disrupted the type I IFN response via increased autophagy. This study reveals a previously unappreciated role for Nrf2 in the regulation of autophagy and the innate antiviral response that complements the therapeutic potential of VSV-directed oncolysis against multiple types of OV-resistant or chemoresistant cancer. Oncolytic viruses offer a promising therapeutic approach to treat cancer. In this issue, Olagnier et al. demonstrate that the antioxidant compound sulforaphane activates the transcriptional regulator Nrf2, leading to suppression of the innate antiviral response, stimulation of autophagy, and enhancement of vesicular stomatitis virus-directed oncolysis of tumor cells.
DOI: 10.1371/journal.pone.0024957
发表时间: 2011
期刊: PloS one
影响因子: 3.7
作者:
Ivanov AV;Smirnova OA;Ivanova ON;Masalova OV;Kochetkov SN;Isaguliants MG
通讯作者: Isaguliants MG
DOI: 10.1073/pnas.172398899
发表时间: 2002-09-03
影响因子: 11.1
作者:
Dinkova-Kostova, AT;Holtzclaw, WD;Talalay, P
通讯作者: Talalay, P
DOI: 10.1073/pnas.1305687110
发表时间: 2013-09-17
影响因子: 11.1
作者:
Baird, Liam;Lleres, David;Dinkova-Kostova, Albena T.
通讯作者: Dinkova-Kostova, Albena T.
DOI: 10.1101/gad.225680.113
发表时间: 2013-10-15
影响因子: 10.5
作者:
Jaramillo MC;Zhang DD
通讯作者: Zhang DD